Below are the latest Company Presentation as well as selected presentations held at recent events. These can be downloaded as PDFs.
Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolone
21 November 2018. Webcast presentation by Thomas Meier, CEO
September 2018 - available here
Swiss Biotech Day 2018 (Basel)
May 3, 2018. Presentation by Thomas Meier, CEO